David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCE
351
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $53.3M | 0.07% |
520,600
+309,229
| +146% | +$33.4M |
|
352
CALL
Merck
MRK
$376B
| $53.3M | 0.07% |
665,899
-382,415
| -36% | -$29.3M |
|
|
PXD
353
DELISTED
Pioneer Natural Resource Co.
PXD
| $52.8M | 0.07% |
343,172
-113,354
| -25% | -$17.4M |
|
354
Halliburton
HAL
$29.4B
| $52.6M | 0.07% |
2,314,633
+1,446,558
| +167% | +$37.5M |
|
355
Thermo Fisher Scientific
TMO
$233B
| $52.6M | 0.07% |
179,183
+54,193
| +43% | +$14.9M |
|
356
CALL
Berkshire Hathaway Class B
BRK.B
$1.06T
| $52.4M | 0.07% |
246,000
+161,000
| +189% | +$33.3M |
|
357
Lam Research
LRCX
$393B
| $52.3M | 0.07% |
2,786,550
+2,649,980
| +1,940% | +$50.3M |
|
|
P
358
Everpure Inc
P
$36.1B
| $52.3M | 0.07% |
3,426,730
+1,585,062
| +86% | +$31M |
|
359
PUT
Blackrock
BLK
$179B
| $52.2M | 0.07% |
111,200
+20,900
| +23% | +$9.45M |
|
360
CALL
Caterpillar
CAT
$381B
| $52M | 0.06% |
381,400
-155,200
| -29% | -$20.5M |
|
361
3M
MMM
$92.3B
| $51.9M | 0.06% |
357,773
+323,909
| +956% | +$49.9M |
|
|
PS
362
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $51.8M | 0.06% |
1,708,335
+758,614
| +80% | +$24.4M |
|
363
Eaton
ETN
$163B
| $51.4M | 0.06% |
617,277
-243,746
| -28% | -$19.7M |
|
364
FedEx
FDX
$76.9B
| $51M | 0.06% |
310,776
-620,655
| -67% | -$109M |
|
365
Acadia Pharmaceuticals
ACAD
$5.08B
| $50.8M | 0.06% |
1,901,850
+461,869
| +32% | +$11.8M |
|
366
CALL
Wells Fargo
WFC
$254B
| $50.8M | 0.06% |
1,073,800
-578,000
| -35% | -$27M |
|
|
DLPH
367
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $50.7M | 0.06% |
2,532,589
+210,152
| +9% | +$4.3M |
|
|
GRA
368
DELISTED
W.R. Grace & Co.
GRA
| $50.5M | 0.06% |
663,048
-374,844
| -36% | -$28.1M |
|
369
Tower Semiconductor
TSEM
$25.2B
| $50.4M | 0.06% |
3,195,793
+61,335
| +2% | +$1.02M |
|
370
Curtiss-Wright
CW
$23.5B
| $50.1M | 0.06% |
394,066
+184,126
| +88% | +$21.2M |
|
371
Zscaler
ZS
$29.4B
| $49.8M | 0.06% |
649,479
-1,156,195
| -64% | -$82.4M |
|
372
East-West Bancorp
EWBC
$17.8B
| $49.8M | 0.06% |
1,063,824
-121,661
| -10% | -$5.83M |
|
373
JPMorgan Chase
JPM
$935B
| $49.7M | 0.06% |
444,494
-514,469
| -54% | -$56.7M |
|
374
Trane Technologies
TT
$99.8B
| $48.7M | 0.06% |
384,645
+73,128
| +23% | +$8.75M |
|
375
Unum
UNM
$13.9B
| $48.7M | 0.06% |
1,450,452
+859,388
| +145% | +$29.8M |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.